Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA expands indication for Genentech cancer drug
Herceptin will be combined with doxorubicin, cyclophosphamide and paclitaxel to treat HER-2 positive early-stage breast cancer patients who have had initial treatment with the goal of reducing the
Herceptin will be combined with doxorubicin, cyclophosphamide and paclitaxel to treat HER-2 positive early-stage breast cancer patients who have had initial treatment with the goal of reducing the
In the study investigators randomized healthy adults to either of two treatments, once-daily SPD465 or Adderall XR followed by mixed amphetamine salts immediate release (MAS IR) administered eight
Helsinn reported that despite some evidence of becatecarin activity, preliminary analysis of the phase III data by an independent data monitoring committee indicated that the comparator agent 5-fluorouracil
The phase I/II study is designed to establish the feasibility, safety and activity of Oncophage vaccination in patients with recurrent, high-grade glioma. Preliminary results from the first cohort
Taranjit Gujral, a PhD student at Queen’s developed three-dimensional models of the mutated RET protein implicated in a condition causing cancerous thyroid tumors. The model allowed him to
Advinus expects to gain $74.5 million for each product and has also received an undisclosed up front payment. Additionally, Advinus will receive royalty payments on sales of the
Using an experimental mouse model of the disorder, the researchers investigated the effects of a non-steroidal anti-inflammatory drug (NSAID) on liver injury. The findings show that the NSAID
Under the terms of the agreement, Pharmion is acquiring Cabrellis for an initial cash payment of $59 million. In addition, Pharmion will make two additional payments of $12.5
Results showed that patients who took Lipitor tablets at 80 mg reduced their risk of heart attack and stroke by 32% compared with patients taking the 10 mg
Earlier this year, initial results from the study suggested that substantial reductions in LDL-C and increases in HDL-C using Crestor are associated with the regression of coronary atherosclerosis.